Balancing The Future

Balancing The Future

By METTLER TOLEDOScienceTechnology
Download on the App Store

Balancing The Future episodes

  • Same-Cell Biology: What Living Cells Could Teach Us

    Traditional high-dimensional molecular profiling has a fundamental limitation: measuring a cell often means destroying it. What could we learn if we could keep cells alive throughout the process?  

       

    In this episode of Balancing the Future, Chai and Micah speak with Tobias Beyer, Chief Scientific Officer at Cystosurge. Cytosurge is a Swiss biotech company that has created a technology called FluidFM (Fluidic Force Microscopy) OMNIUM.  

      

    FluidFM builds on atomic force microscopy, which has been used to study cells since the mid-1980s. The technique uses a tiny tip to map a cell’s surface.  

       

    FluidFM combines fluid dynamics with a hollow cantilever to interact gently with cells without destroying them. Applications include measuring cell adhesion, delivering DNA and RNA into cells, and gene editing.   

      

    Tobias suggests that the comparative data generated by this technology could help build datasets for machine learning in the future.  

      

    The next step is to increase the technology’s throughput. FluidFM currently works with one cell at a time, with users able to extrapolate from those individual measurements.  

     

    LINKS: 

    • Tobias Beyer on LinkedIn 
    • Cytosurge Website 
    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

     

    EPISODE SOURCES: 

    Live-seq enables temporal transcriptomic recording of single cells - Nature 

    Peking University and Qingdi Quantum Achieve Major Progress in Single-Cell Adhesion Dynamics - Cytosurge 

     

    ABOUT BALANCING THE FUTURE: 

     

    Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  

      

    We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

      

    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode. 

     

    ABOUT METTLER TOLEDO: 


    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 

    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone

    20 min
  • Biosimilars at a Turning Point: Market Growth, Regulation, and Access

    Biologic medicines have transformed the treatment of many diseases, but access and affordability remain important challenges across healthcare systems. Could biosimilars offer a solution? 

      

    In this episode of Balancing the Future, Chai and Micah speak with Andrew Bourgoin, founder of the Bourgoin Insights Group. Andrew has more than 15 years of experience working across the biosimilars field, from market access to business development.  

      

    Biosimilars are biological medicines that are highly similar to an approved reference biologic. Unlike medicines produced by mixing chemicals or through other synthetic processes, they are created using living cells. Scientists study the originator medicine to identify the genetic instructions needed to produce it, then insert those instructions into living cells. 

     

    When a biosimilar enters the market, it increases competition and, because the originator drug’s patent has expired, ends any monopoly a company may have over that drug. Together, these factors lower costs for physicians, patients and other stakeholders. 

     

    In 2026, the U.S. Food and Drug Administration approved it’s 100th biosimilar — a milestone that Andrew believes signals continued growth in the market. Another important development announced across 2025 and 2026 reduced the requirement for third-stage clinical trials from the biosimilar regulatory process. Previously, biosimilars had to undergo these trials to demonstrate that they were highly similar to the originator drug. Now, earlier-stage laboratory testing can provide that evidence.  

       

    Andrew points out that the field’s direction is becoming clearer, with biosimilars in development for treatments ranging from food allergies to retinal conditions.  

     

    LINKS: 

    • Andrew Bourgain on LinkedIn 
    • Bourgoin Insights Group Website 
    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

     

    EPISODE SOURCES: 

    Biosimilar Product Information – US. Food and Drug Administration 

    How does health spending in the U.S. compare to other countries? - Health System Tracker 

    FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs - US. Food and Drug Administration 


    ABOUT BALANCING THE FUTURE: 

     

    Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  

      

    We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

      

    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode. 

     

    ABOUT METTLER TOLEDO: 


    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 

    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone.

    22 min
  • Cell-Free Bioengineering: The New Chemical Manufacturing Frontier

    In traditional chemical manufacturing, multiple chemical reactions must take place before the desired final product is achieved. Even then, purity and yield can be extremely low. Biological processes can be complex and produce unwanted by-products. However, removing the cell entirely could offer a way forward and reduce the time from idea to market. 

       

    In this episode of Balancing the Future, Chai speaks with Damien Perriman, Chief Commercial Officer at eXoZymes, a biotechnology company developing cell-free biomanufacturing platforms using AI and bioengineered enzymes.  

     

    Typically, enzymes catalyze chemical reactions, converting one molecule into another. An ‘exozyme’ is created by removing an enzyme from a cell and bioengineering it for use as a catalyst in a bioreactor. This makes the process controllable and scalable. Damien says this can reduce processes that once took years to just months, while also shortening the time from creation to market. 

     

    So far, eXoZymes has created several chemicals and other molecules using these processes. The company has focused particularly on non-psychoactive cannabinoids and their potential health benefits. It has also worked with N-trans-caffeoyl tyramine a regulator that governs mitochondrial function and fat metabolism across the liver and muscles.  

       

    Damien also gives a glimpse into eXoZyme’s path ahead. Future areas of exploration may include women's health, companions for GLP-Ones, and much more.   

     

    LINKS: 

    • Damien Perriman on LinkedIn 
    • eXoZymes Website 
    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

     

    EPISODE SOURCES: 

    Eduard Buchner – Encyclopedia Britannica 

     

    ABOUT BALANCING THE FUTURE: 

    Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  

      

    We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

      

    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode.


    ABOUT METTLER TOLEDO:
     
    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 

    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone.

    21 min
  • We're Taking a Break!

    Balancing the Future is taking a few weeks off. Join Micah and Chai later this month for more conversations about the science and technology solutions transforming our lives. 

     

    In the meantime, you can listen to all previous episodes on your podcast app of choice.  

     

    LINKS: 

    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

     

    ABOUT BALANCING THE FUTURE: 

     

    Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  

      

    We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

      

    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode. 

     


    ABOUT METTLER TOLEDO:
     
    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 

    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone. 

    1 min
  • Plastic-Derived Cookies: From Pollution to Nutrition

    The International Union for Conservation of Nature estimates that more than 20 million metric tons of plastic waste enter the environment each year. At the same time, the UN World Food Programme warns that 266 million people worldwide face acute hunger in 2026. Could a single solution help address both challenges? Two scientists at Southern Illinois University Carbondale believe it could.  

      

    In this episode of Balancing the Future, Micah speaks with associate professor and microbiologist Dr. Lahiru Jayakody and graduate research assistant Sandhya Jayasekara at Southern Illinois University Carbondale about how they transformed polyethylene terephthalate (PET) bottles into cookies that look and smell like those on supermarket shelves.   

      

    The project is built on a surprisingly simple idea: plastic and food both contain carbon, so could one be transformed into the other? Using a proprietary method called oxidative hydrothermal dissolution, the researchers process carbon-rich materials such as PET plastic, discarded corn stalks and leaves, and another biomass.  

     

    The process uses water and oxygen at suitable temperatures and pressures to break down tough materials into components that microbes can access. These components are then fed to specially programmed yeasts, which convert them into food ingredients such as proteins, fats, and acids. The researchers add fiber, starch, and sweetener, then extrude the mixture through a 3D printer to create protein-rich cookies called µBites (microbites).  

      

    The project was inspired not only by these two major societal challenges, but also by NASA's Deep Space Food Challenge, which called for ideas for sustainable food systems for Moon and Mars missions. Lahiru envisions a future in which plastic packaging used by astronauts could be repurposed as a food source during long space missions.  

     

    In August 2026, a global communications campaign introduced the derived plastic cookie to the world. Lahiru and Sandhya reflect on the divided public response to the idea and the lessons they have learned about explaining novel scientific concepts to a wider audience.   

      

    The cookie remains a work in progress, with researchers now focused on confirming its safety to eat. If they clear that hurdle, these small cookies could have a significant global impact.  

     

    LINKS: 

    • Dr. Lahiru Jayakody Bio 
    • Sandhya Jayasekara on LinkedIn 
    • NASA Deep Space Food Challenge Website 
    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

    EPISODE SOURCES: 

    • This cookie started its life as a plastic bottle – The American Chemical Society 
    • Hard to swallow? The future of snacking may be 3D-printed cookies made from upcycled plastic – The Guardian 
    • Plastic pollution – The International Union for Conservation of Nature 
    • A global food crisis – The UN World Food Programme 
    • Microbes transform plastic waste into paracetamol – The University of Edinburgh 

    ABOUT BALANCING THE FUTURE: 

    Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  


    We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

      

    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode. 


    ABOUT METTLER TOLEDO:
     

    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 

    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone. 

    21 min
  • Mushroom Boxes: The Nature-Inspired Solution Making Cold Chain Sustainable

    The cold chain industry helps move food, vaccines, and other perishable goods around the world. But it also has a big carbon footprint, so finding cleaner, smarter ways to improve the system is really important. 

     

    In this episode of Balancing the Future, Chai and Micah sit down with Tapasvi Bhatt, a PhD scholar from Nanyang Technological University in Singapore and winner of the 2026 METTLER TOLEDO Innovator Award. Along with his peer researchers, he built a way to lower the cold chain’s carbon footprint: a box made from mushrooms. 

     

    Tapasvi explains that cold chain boxes are often insulated with non-recyclable materials like petrochemical foams or polyurethane, which take a long time to break down. On top of that, it is usually cheaper to make a new box than to return and reuse the original, adding even more carbon emissions to the supply chain. 

     

    That’s why Tapasvi and his team developed a box made from a mycelium composite, which is a mix of mycelium, oats, and other biodegradable materials. These boxes insulate well, can be reused several times, and break down easily in soil. If widely adopted, this technology could significantly reduce the cold chain industry’s carbon footprint. 

     

    Micah and Chai also discuss other possible uses for mycelium composite, including building materials, furniture, and even coffins. 

      

    LINKS: 

    • Tapasvi Bhatt on LinkedIn 
    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

    EPISODE SOURCES: 

    • METTLER TOLEDO Innovator Award 
    • The Growing Pavillion, Amsterdam, The Netherlands 
    • The Hy Fi Pavillion, New York City, USA 
    • 7 Unexpected Uses Of Mycelium Composites You’ll Love Knowing – Bina Biox 

     ABOUT BALANCING THE FUTURE: 

     Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  

      

    We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

      

    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode. 

     

    ABOUT METTLER TOLEDO: 
    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 

    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone.

    21 min
  • Out of Thin Air: The New Device Reinventing Water Production

    According to the World Health Organization and UNICEF, one in four people around the world lack access to drinking water. Many people also spend over thirty minutes each day just collecting it. Meanwhile, the growth of data centers for AI is putting more pressure on water and land resources. Is it possible that a small device could help solve these big problems? 


    In this episode of Balancing the Future, Chai sits down with Dr. Carlos Diaz-Marin, Assistant Professor of Energy Science and Engineering at the Stanford Doerr School of Sustainability and winner of the 2026 METTLER TOLEDO Innovator Award.  


    They discuss Carlos and his team’s invention, a small box that uses the same technology found in diapers and other absorbent materials. It pulls moisture from the air and stores it as drinking water. The device runs on solar power, so it works reliably and sustainably. While the basic technology has been around for a while, what sets this device apart is that it can operate even in very low humidity, which has been a challenge for similar products. 

      

    Carlos and his team have tested the device in extreme environments, including the rainforest and the world's driest desert. They found that it worked well in all these places. This means the device could be used in homes to provide enough drinking water for a family each day. Its ability to use waste heat could also make it useful for cooling AI data centers. 

     

    LINKS: 

    • Dr. Carlos Diaz-Marin Bio 
    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

     

    EPISODE SOURCES: 

    • METTLER TOLEDO Innovator Award 
    • Solar-driven atmospheric water harvesting in the Atacama Desert through physics-based optimization of a hygroscopic hydrogel device – Device Journal 
    • 1 in 4 people globally still lack access to safe drinking water – WHO, UNICEF
    • Rising Emissions, Depleting Water and Vanishing Land—UN Scientists: AI Is Threatening Natural Resources for Billions – United Nations University Institute for Water, Environment and Health 
    • UN World Water Development Report 2026 – United Nations 


    ABOUT BALANCING THE FUTURE: 

    Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  

      

    We explore a wide range of creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

      

    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode. 

     


    ABOUT METTLER TOLEDO:

    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 

    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone.

    19 min
  • Treatable by Design: Rethinking How We Make Chemicals

    It’s widely recognized that many persistent chemicals pose risks to both environmental and human health. Addressing this significant global challenge requires innovative solutions. One of these is the groundbreaking concept of ‘Treatable by Design’.  


    In this episode of Balancing the Future, Chai and Micah sit down with Dr. Gabriel Sigmund, Associate Professor at Wageningen University & Research to discuss his approach for developing safer chemicals that are intentionally designed to degrade rapidly and exhibit low toxicity.  


    His strategy targets substances such as PFAS (per- and polyfluoroalkyl substances), which are commonly used for their water- and oil-resistant properties but are, as a result, extremely hard to break down. Gabriel describes this as a cascade: if a chemical cannot be made safe by design, the first step is to look for a safer alternative. If no alternative exists, the chemical should be made treatable by design. Failing that, the search returns to finding an alternative that is treatable. This cycle repeats through several stages before arriving at the final case, one where the chemical simply cannot be dealt with. At that point, Gabriel argues, the real question becomes whether the chemical is necessary at all. More often than not, he suggests, the answer is no. 

     

    A second line of defense for addressing toxic chemicals involves removing them from the environment through techniques such as water filtration and incineration. Although remediation efforts are underway, their pace remains insufficient. Gabriel emphasizes that even if affluent nations allocated all available resources, it would still be impossible to eliminate every hazardous chemical from the environment. 

     

    Overall, Gabriel advocates for a pragmatic approach: reducing the production of harmful chemicals now will decrease the need for future remediation. 

     

    LINKS: 

    • Dr. Gabriel Sigmund Bio 
    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

    EPISODE SOURCES: 

    A concept for the molecular design of readily treatable chemicals – Royal Society of Chemistry

    With over 100 new alternatives to PFAS, ChemSec Marketplace becomes key industry resource – ChemSec 

    Persistence Assessment of Chemicals: Trajectories toward New Approach Methodologies (P-NAMs) – ACS Publications 

    Support for EU-wide PFAS restriction with targeted derogations: what happens next? – CMS Law 

    Europe’s PFAS restriction proposal is moving forward – White and Case 

     

    ABOUT BALANCING THE FUTURE: 

    Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  

     
    We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

      

    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode. 

     

    ABOUT METTLER TOLEDO 
    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 
    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone.

    21 min
  • Space Economy: A New Frontier for Future Medicine

    By 2026 80% of the 500 pharmaceutical and industrial crystals produced in space exhibited better structure, greater consistency, and fewer defects. So, what does that tell us about the rapidly growing space economy — and how far could microgravity take manufacturing? 

     

    In this episode of Balancing the Future, Micah sits down with Mari Anne Snow, CEO and Co-Founder of Eascra Biotech. Eascra is a US-based company developing delivery technology for a wide range of therapeutic payloads — from mRNA and siRNA to proteins and peptides. Their technology is especially effective at penetrating very dense tissues such as cartilage, kidneys, and solid tumors. 

     

    Mari Anne shares the story of how her co-founder was given the chance and the funding by NASA to turn their work into a so-called “space product.” After sending it to the International Space Station, they discovered that the microgravity environment boosted the product’s effectiveness by an impressive 40–50%. 

     

    But that breakthrough also came with a new set of challenges. How do you build a supply chain that reaches 250 miles above Earth? How do you scale production in a place where creating new manufacturing space isn’t as simple as putting up a few extra walls? And what happens when regulations and governance on Earth collide with those in space? 

     

    Mari Anne believes we’re only at the very tip of the iceberg when it comes to what can be invented and produced off planet. From colonizing the Moon to space tourism, she argues that manufacturing in space won’t just support those ambitions; it could become the slingshot that propels us to the stars. 

    LINKS: 

    • Eascra Biotech Website 
    • Mari Anne Snow on LinkedIn 
    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

     

    EPISODE SOURCES: 

    20 Inventions We Wouldn't Have Without Space Travel – The Jet Propulsion Laboratory at California Institute of Technology 

    In Space for Earth: Breakthroughs from the ISS – The National Space Society (NSS) 

    Optical Fiber Production – NASA 

    NASA’s new superalloy – Aerospace America 

     

    ABOUT BALANCING THE FUTURE: 

    Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  

      

    We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

      

    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode. 

     
    ABOUT METTLER TOLEDO 

    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 

    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone.

    20 min
  • The Road to Market: How Regulations Shape the Future of Medical Devices

    Medical devices range from simple fillings to highly sophisticated robotics, with more than half a million available in the EU alone. However, regulations differ widely across regions and countries. What does this mean for medical device development around the world? 


    In this episode of Balancing the Future, Micah and Chai interview Dr. Dominik Lysek, Executive Board Member and CEO of PharmaTrail, a software company that helps pharmaceutical, biotech, and medtech companies manage clinical trial data with blockchain technology. Dominik has worked with medical devices throughout his career and has closely followed both the EU and US markets. 


    Dominik explains how the EU and the US each regulate their medical device markets. One key difference is that the US provides clear timelines for approvals, while Europe does not set specific deadlines. In the EU, even a modified version of an already approved and safe product still needs to go through regulatory approval. However, new Medical Device Regulation 2.0 legislation now being considered by the EU parliament could change this by introducing clear deadlines and reducing bureaucracy. 


    Even with these possible changes, both the EU and US still require strong and reliable data to approve new products. MDR 2.0 will allow different types of clinical data, like in vitro and model data, to be included in applications. Dominik emphasizes that a rigorous process is important so patients can trust and benefit from the medical devices they use. He believes the industry should always put patients first. 

     

    LINKS: 

    • PharmaTrail Website 
    • Dominik Lysek on LinkedIn 
    • METTLER TOLEDO Website 
    • METTLER TOLEDO on LinkedIn 
    • Balancing The Future Podcast Website 
    • Micah Schweizer on LinkedIn 
    • Chai Nussbaumer on LinkedIn 

    EPISODE SOURCES: 

    • Premarket Review: Laboratory Developed Tests FAQs – U.S. Food and Drug Administration 
    • Navigating the NMPA Registration Process: Timelines, Costs, and Considerations – Medtech Chopsticks 
    • The EU’s 2025 proposal to simplify the Medical and In-Vitro-Diagnostic Devices Regulations (MDR/IVDR) - Healthcare & Life Sciences Blog 
    • EU Device Reform Package: Fee Relief, Down-Classification, and More – Cacus Consulting 

     

    ABOUT BALANCING THE FUTURE: 

     Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.  

      

    We explore wide-ranging creative solutions that are changing our world for the better. You will hear directly from people making an impact in science and technology, such as, how cultivated foods could shake up both our diets and traditional agriculture, the ways AI might help us find a cure for Alzheimer's, and how tiny 3D ‘organoids’ are already changing the way we test new drugs.  

     
    Each episode offers hopeful conversations with scientists, leaders and communicators who are making a difference in their fields.   

      

    Join us as we decode the mechanisms behind impactful developments and new ways of thinking. Subscribe or follow us to be sure you never miss an episode. 

     

    ABOUT METTLER TOLEDO 
    Whether ensuring food safety, developing life-saving medicines, or advancing new technologies, precision, efficacy and accuracy matters. Meeting customers’ expectations takes more than effort; it requires the right partner. 

    METTLER TOLEDO supports with trusted tools, expertise, and knowledge. Together, we help our clients work more efficiently, stay compliant, and drive innovation, building a safer and more sustainable future for everyone.

    21 min

About Balancing The Future

From the publisher's feed

Science and technology play a key role in solving many of the world’s toughest problems. Balancing the Future introduces listeners to the people and innovations addressing these challenges.